virax is bottoming, page-2

Hey PA this is my understanding of where Virax is at, can you let me know if there is any other news?

interim clinical data expected prior April 2011 for TG4001/R3484
Therapeutic Vaccine AKA treatment of cervical cancer caused by human papilloma Virus 16 and HPV 16 related infections

Still awaiting formal licensing agreement for the skin cancer treatment and of course cash which will need to part of the deal, maybe get this before July 2011.
clinical trials to possibly start before December 2011.

NEWS of a purchase of TG4010 may occur Jan 2012 - April 2012, which may inject as little as 3Mil A$ into Virax's coffers or tens of millions of dollars, precise information is unavailable.
Note the company (Virax) expected milestone payments, however these are unlikely.

As Virax have alluded to, they need to Sell something and fairly quickly to maintain funds in the business, obviously not the best position to be in when trying to achieve maximum return for shareholders.

VIR201 has little to nothing to add for shareholders in the next couple of years at least. Although the mass reduction of Load did occur if only briefly.


cheers